ATE404214T1 - Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält - Google Patents

Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält

Info

Publication number
ATE404214T1
ATE404214T1 AT01102385T AT01102385T ATE404214T1 AT E404214 T1 ATE404214 T1 AT E404214T1 AT 01102385 T AT01102385 T AT 01102385T AT 01102385 T AT01102385 T AT 01102385T AT E404214 T1 ATE404214 T1 AT E404214T1
Authority
AT
Austria
Prior art keywords
small
medium size
product containing
medicinal product
size peptide
Prior art date
Application number
AT01102385T
Other languages
English (en)
Inventor
Wayne Woodrow
Original Assignee
Patents Expl Company B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patents Expl Company B V filed Critical Patents Expl Company B V
Application granted granted Critical
Publication of ATE404214T1 publication Critical patent/ATE404214T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01102385T 2000-02-04 2001-02-02 Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält ATE404214T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00102429 2000-02-04

Publications (1)

Publication Number Publication Date
ATE404214T1 true ATE404214T1 (de) 2008-08-15

Family

ID=8167782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01102385T ATE404214T1 (de) 2000-02-04 2001-02-02 Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält

Country Status (4)

Country Link
US (1) US6949509B2 (de)
JP (1) JP2001233787A (de)
AT (1) ATE404214T1 (de)
DE (1) DE60135261D1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
AU2006326418A1 (en) * 2005-12-16 2007-06-21 Argolyn Bioscience, Inc. Non-natural amino acids and neurotensin analogues thereof
PL2389923T3 (pl) * 2010-05-19 2013-06-28 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia iniekcyjny preparat paracetamolu
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
US11389473B2 (en) 2015-01-07 2022-07-19 Tonix Pharmaceuticals Holding Corp. Magnesium-containing oxytocin formulations and methods of use
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
MX2018012351A (es) 2016-04-12 2019-02-07 Trigemina Inc Formulaciones de oxitocina que contienen magnesio y metodos de uso.
US11318183B2 (en) 2018-03-20 2022-05-03 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
JP2025535575A (ja) * 2022-11-09 2025-10-24 ヒクマ ファーマシューティカルズ ユーエスエイ インコーポレイテッド バソプレシン製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853375A (en) * 1987-09-16 1989-08-01 The Trustees Of The University Of Pennsylvania Method of lowering intraocular (eye) pressure
SE9300105D0 (sv) * 1993-01-15 1993-01-15 Kabi Pharmacia Ab Stable protein solution
RU2135204C1 (ru) 1993-06-29 1999-08-27 Ферринг Б.В. Составы для назального введения десмопрессина
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin

Also Published As

Publication number Publication date
DE60135261D1 (de) 2008-09-25
US6949509B2 (en) 2005-09-27
US20010027177A1 (en) 2001-10-04
JP2001233787A (ja) 2001-08-28

Similar Documents

Publication Publication Date Title
DE60135261D1 (de) Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
DE60015112D1 (de) Peptidextrakt aus lupinen und pharmazeutische oder kosmetische oder pharmaco-nahrungsmittel zusammensetzung, die so ein extrakt enthalten
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
DE69808130D1 (de) Adamantan-derivate
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
DE69018647D1 (de) Arzneimittel.
ITRM920381A1 (it) Composizione farmaceutica per applicazione topica, quale smalto per unghie.
PT1036058E (pt) Deribvados de adamantano
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
ITFI930083A0 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
BG103714A (en) Pararacetamol-containing tablet
ATE310496T1 (de) Kosmetisches schlankheidsmittel enthaltend einen pflanzen extrakten mit einem natriuretischem peptid
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
WO2002011724A3 (en) Neuroprotective 2-pyridinamine compositions and related methods
HK1054033A1 (zh) 4-嘧啶胺衍生物、药用组合物和相关方法
DE69821001D1 (de) Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält
CA2402708A1 (en) Torasemide-containing pharmaceutical preparations
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
DK0758905T3 (da) Hirudinholdige farmaceutiske præparater
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties